Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study

Background: Plasma-based biomarkers would be potential biomarkers for early diagnosis of Alzheimer's disease (AD) because they are more available and cost-effective than cerebrospinal fluid (CSF) or neuroimaging. Therefore, we aimed to evaluate whether phosphorylated tau181 (p-tau181) in plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan-Li, Chen, Jinglong, Du, Zhong-Li, Weng, Haoyi, Zhang, Yuan, Li, Runzhi, Jia, Ziyan, Sun, Mengfan, Jiang, Jiwei, Wang, Fang-Ze, Xu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452983/
https://www.ncbi.nlm.nih.gov/pubmed/34557143
http://dx.doi.org/10.3389/fneur.2021.695696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452983/
https://www.ncbi.nlm.nih.gov/pubmed/34557143
http://dx.doi.org/10.3389/fneur.2021.695696

Ejemplares similares